A detailed history of Level Four Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 134,719 shares of ABBV stock, worth $23.1 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
134,719
Previous 123,260 9.3%
Holding current value
$23.1 Million
Previous $21.1 Million 25.84%
% of portfolio
1.16%
Previous 1.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.88 Million - $2.28 Million
11,459 Added 9.3%
134,719 $26.6 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $1.79 Million - $2.09 Million
-11,585 Reduced 8.59%
123,260 $21.1 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $435,988 - $496,768
2,728 Added 2.06%
134,845 $24.6 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $252,358 - $284,214
1,834 Added 1.41%
132,117 $20.5 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $6.12 Million - $7.09 Million
-45,817 Reduced 26.02%
130,283 $19.4 Million
Q2 2023

Jul 10, 2023

SELL
$132.51 - $164.9 $6.06 Million - $7.54 Million
-45,730 Reduced 20.61%
176,100 $23.7 Million
Q1 2023

Jun 05, 2023

BUY
$144.61 - $166.54 $12 Million - $13.8 Million
82,694 Added 59.43%
221,830 $35.4 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $5.98 Million - $7.18 Million
43,265 Added 45.13%
139,136 $22.5 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $374,043 - $429,002
-2,787 Reduced 2.82%
95,871 $12.9 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $901,411 - $1.15 Million
-6,550 Reduced 6.23%
98,658 $15.1 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $192,426 - $238,747
1,458 Added 1.41%
105,208 $17.1 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $3 Million - $3.8 Million
27,946 Added 36.87%
103,750 $14 Million
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $1.56 Million - $1.77 Million
-14,660 Reduced 16.21%
75,804 $8.18 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $1.06 Million - $1.18 Million
10,047 Added 12.49%
90,464 $10.2 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $556,102 - $612,202
-5,436 Reduced 6.33%
80,417 $8.7 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $552,402 - $745,802
-6,863 Reduced 7.4%
85,853 $9.2 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $707,554 - $830,435
-8,236 Reduced 8.16%
92,716 $8.12 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $7.1 Million - $9.5 Million
96,770 Added 2313.96%
100,952 $9.89 Million
Q2 2020

Jul 27, 2020

SELL
$73.37 - $98.18 $4.74 Million - $6.34 Million
-64,579 Reduced 93.92%
4,182 $411,000
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $688,795 - $1.04 Million
10,679 Added 18.39%
68,761 $5.24 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $168,712 - $211,094
2,339 Added 4.2%
58,082 $17.2 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $925,302 - $1.11 Million
14,692 Added 35.79%
55,743 $4.22 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $72,795 - $93,049
1,108 Added 2.77%
41,051 $2.98 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $125,892 - $148,169
-1,632 Reduced 3.93%
39,943 $3.22 Million
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $93,653 - $115,500
1,203 Added 2.98%
41,575 $3.83 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $414,676 - $460,989
-4,664 Reduced 10.36%
40,372 $3.82 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $899,775 - $1.06 Million
-10,022 Reduced 18.2%
45,036 $4.17 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $7,452 - $9,980
-81 Reduced 0.15%
55,058 $5.21 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $12,538 - $13,749
-140 Reduced 0.25%
55,139 $5.33 Million
Q3 2017

Apr 03, 2018

SELL
$69.85 - $89.22 $127,057 - $162,291
-1,819 Reduced 3.19%
55,279 $4.91 Million
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $858,037 - $1.1 Million
12,284 Added 27.41%
57,098 $5.16 Million
Q2 2017

Sep 20, 2017

SELL
N/A
-13,959 Reduced 23.75%
44,814 $2.91 Million
Q1 2017

Sep 20, 2017

BUY
N/A
58,773
58,773 $3.82 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.